Search by Drug Name or NDC
NDC 50090-2062-00 TENIVAC 5; 2 [Lf]/.5mL; [Lf]/.5mL Details
TENIVAC 5; 2 [Lf]/.5mL; [Lf]/.5mL
TENIVAC is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by A-S Medication Solutions. The primary component is CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED).
MedlinePlus Drug Summary
Why get vaccinated? Td vaccine can prevent tetanus and diphtheria. Tetanus enters the body through cuts or wounds. Diphtheria spreads from person to person. TETANUS (T) causes painful stiffening of the muscles. Tetanus can lead to serious health problems, including being unable to open the mouth, having trouble swallowing and breathing, or death. DIPHTHERIA (D) can lead to difficulty breathing, heart failure, paralysis, or death.
Related Packages: 50090-2062-00Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Tetanus, Diphtheria (Td) Vaccine
Product Information
| NDC | 50090-2062 |
|---|---|
| Product ID | 50090-2062_c4b2e759-0f3e-470e-aae5-048e92315ea2 |
| Associated GPIs | 18990002202210 |
| GCN Sequence Number | 063696 |
| GCN Sequence Number Description | tetanus-diphtheria toxoids/PF SYRINGE 5-2/0.5ML INTRAMUSC |
| HIC3 | W7Z |
| HIC3 Description | VACCINE/TOXOID PREPARATIONS,COMBINATIONS |
| GCN | 99414 |
| HICL Sequence Number | 035399 |
| HICL Sequence Number Description | TETANUS AND DIPHTHERIA TOXOIDS, ADSORBED, ADULT/PF |
| Brand/Generic | Generic |
| Proprietary Name | TENIVAC |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) and CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 5; 2 |
| Active Ingredient Units | [Lf]/.5mL; [Lf]/.5mL |
| Substance Name | CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED); CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED) |
| Labeler Name | A-S Medication Solutions |
| Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Diphtheria Toxoid [CS], Inactivated Clostridium Tetani Vaccine [EPC], Inactivated Corynebacterium Diphtheriae Vaccine [EPC], Tetanus Toxoid [CS], Vaccines, Inactivated [CS], Vaccines, Inact |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103171 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 50090-2062-00 (50090206200)
| NDC Package Code | 50090-2062-0 |
|---|---|
| Billing NDC | 50090206200 |
| Package | 10 SYRINGE in 1 PACKAGE (50090-2062-0) / .5 mL in 1 SYRINGE (50090-2062-1) |
| Marketing Start Date | 2010-12-08 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |